Costing Behavioral Interventions: A Practical Guide to Enhance Translation

Background/PurposeCost and cost effectiveness of behavioral interventions are critical parts of dissemination and implementation into non-academic settings. Due to the lack of indicative data and policy makers’ increasing demands for both program effectiveness and efficiency, cost analyses can serve as valuable tools in the evaluation process.MethodsTo stimulate and promote broader use of practical techniques that can be used to efficiently estimate the implementation costs of behavioral interventions, we propose a set of analytic steps that can be employed across a broad range of interventions.Results/ConclusionsIntervention costs must be distinguished from research, development, and recruitment costs. The inclusion of sensitivity analyses is recommended to understand the implications of implementation of the intervention into different settings using different intervention resources. To illustrate these procedures, we use data from a smoking reduction practical clinical trial to describe the techniques and methods used to estimate and evaluate the costs associated with the intervention. Estimated intervention costs per participant were $419, with a range of $276 to $703, depending on the number of participants.

[1]  E. Rogers,et al.  Diffusion of innovations , 1964, Encyclopedia of Sport Management.

[2]  S. Shiffman,et al.  Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  M. Stebbins,et al.  Evaluation of the Relationship Between a Chronic Disease Care Management Program and California Pay-for-Performance Diabetes Care Cholesterol Measures in One Medical Group , 2007, Journal of managed care pharmacy : JMCP.

[4]  R. Glasgow,et al.  Tailored behavioral support for smoking reduction: development and pilot results of an innovative intervention. , 2007, Health education research.

[5]  D. Stryer,et al.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. , 2003, JAMA.

[6]  M. Fiore,et al.  Organization, financing, promotion, and cost of U.S. quitlines, 2004. , 2007, American journal of preventive medicine.

[7]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[8]  R. Richmond,et al.  Cost-effectiveness analysis of a family physician delivered smoking cessation program. , 2000, Preventive medicine.

[9]  P. Fishman,et al.  Health care costs among smokers, former smokers, and never smokers in an HMO. , 2003, Health services research.

[10]  Á. Helgason,et al.  Quitline in smoking cessation: A cost-effectiveness analysis , 2004, International Journal of Technology Assessment in Health Care.

[11]  Jeffrey R. Harris,et al.  Priorities among recommended clinical preventive services. , 2001, American journal of preventive medicine.

[12]  K. W. Harris,et al.  The Guide to Community Preventive Services , 2005 .

[13]  Russell E Glasgow,et al.  Problem Solving and Diabetes Self-Management , 2007, Diabetes Care.

[14]  S. Teutsch,et al.  Lessons from cost-effectiveness research for United States public health policy. , 2007, Annual review of public health.

[15]  Lisa M Klesges,et al.  The future of health behavior change research: What is needed to improve translation of research into health promotion practice? , 2004, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[16]  W. Groot,et al.  Systematic Review of Economic Evaluations of Smoking Cessation: Standardizing the Cost-Effectiveness , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  K. Whetten-Goldstein,et al.  Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. , 1997, Social science & medicine.

[18]  R. Kaplan,et al.  Applications of cost-effectiveness methodologies in behavioral medicine. , 2002, Journal of consulting and clinical psychology.

[19]  Pierre-Andre La Chance,et al.  Cost-effectiveness of a hospital-based smoking cessation intervention. , 1998, Medical care.

[20]  U. Reinhardt Making economic evaluations respectable. , 1997, Social science & medicine.

[21]  F. Paccaud,et al.  Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison , 2006, Tobacco Control.

[22]  P. Donnan,et al.  Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial , 2001, BMJ : British Medical Journal.

[23]  L. Rips,et al.  Answering autobiographical questions: the impact of memory and inference on surveys. , 1987, Science.

[24]  P. Fishman,et al.  Changes in health care costs before and after smoking cessation. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  M. Drummond,et al.  Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[26]  K. Emmons,et al.  How can we increase translation of research into practice? Types of evidence needed. , 2007, Annual review of public health.

[27]  A. Koriat How do we know that we know? The accessibility model of the feeling of knowing. , 1993 .

[28]  R. Glasgow,et al.  Economic Analysis of the Mediterranean Lifestyle Program for Postmenopausal Women With Diabetes , 2006, The Diabetes educator.

[29]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997 .

[30]  J. Matthews,et al.  The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking , 2007, Cost effectiveness and resource allocation : C/E.

[31]  P. Franks,et al.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. , 1996, JAMA.

[32]  Paul A Estabrooks,et al.  Practical Clinical Trials for Translating Research to Practice: Design and Measurement Recommendations , 2005, Medical care.

[33]  Ping Zhang,et al.  Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. , 2003, Diabetes care.

[34]  D. Ilardi,et al.  Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation , 2008, BJOG : an international journal of obstetrics and gynaecology.